Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Covington
QuintilesIMS
Mallinckrodt
Moodys
Boehringer Ingelheim
Accenture
Queensland Health
McKesson

Generated: September 21, 2018

DrugPatentWatch Database Preview

Meridian Medcl Techn Company Profile

« Back to Dashboard

What is the competitive landscape for MERIDIAN MEDCL TECHN, and what generic and branded alternatives to MERIDIAN MEDCL TECHN drugs are available?

MERIDIAN MEDCL TECHN has four approved drugs.



Summary for Meridian Medcl Techn
US Patents:0
Tradenames:4
Ingredients:4
NDAs:4

Drugs and US Patents for Meridian Medcl Techn

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Meridian Medcl Techn ATROPEN atropine sulfate SOLUTION;INTRAMUSCULAR 017106-004 Sep 17, 2004 RX Yes Yes ➤ Sign Up ➤ Sign Up
Meridian Medcl Techn MORPHINE SULFATE morphine sulfate INJECTABLE;INJECTION 019999-001 Jul 12, 1990 RX Yes Yes ➤ Sign Up ➤ Sign Up
Meridian Medcl Techn ATROPEN atropine sulfate SOLUTION;INTRAMUSCULAR 017106-003 Jun 19, 2003 RX Yes Yes ➤ Sign Up ➤ Sign Up
Meridian Medcl Techn ATROPEN atropine sulfate SOLUTION;INTRAMUSCULAR 017106-002 Jun 19, 2003 RX Yes Yes ➤ Sign Up ➤ Sign Up
Meridian Medcl Techn LIDOPEN lidocaine hydrochloride INJECTABLE;INJECTION 017549-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Meridian Medcl Techn PRALIDOXIME CHLORIDE pralidoxime chloride INJECTABLE;INJECTION 018986-001 Apr 26, 1983 RX Yes Yes ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Boehringer Ingelheim
UBS
Dow
QuintilesIMS
McKinsey
Deloitte
Queensland Health
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.